Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 

Prognosis of Restrictive cardiomyopathy

Prognosis of Restrictive cardiomyopathy: Poor. 5-year survival only about 30%. ...see also Overview of Restrictive cardiomyopathy

Prognosis for Restrictive cardiomyopathy: The condition is similar to dilated cardiomyopathy and tends to worsen with time. Only about 30 percent of patients survive more than 5 years after diagnosis. (Source: excerpt from NHLBI, Cardiomyopathy: NHLBI) ...see also Overview of Restrictive cardiomyopathy

Life Expectancy and Survival Rates

5-year survival rate for Restrictive cardiomyopathy: Only about 30 percent of patients survive more than 5 years after diagnosis. (Source: excerpt from NHLBI, Cardiomyopathy: NHLBI)

Complications:

Complications of Restrictive cardiomyopathy from the Diseases Database include:


Source: Diseases Database

See also complications of Restrictive cardiomyopathy.

Restrictive cardiomyopathy: Research More

About prognosis:

The 'prognosis' of Restrictive cardiomyopathy usually refers to the likely outcome of Restrictive cardiomyopathy. The prognosis of Restrictive cardiomyopathy may include the duration of Restrictive cardiomyopathy, chances of complications of Restrictive cardiomyopathy, probable outcomes, prospects for recovery, recovery period for Restrictive cardiomyopathy, survival rates, death rates, and other outcome possibilities in the overall prognosis of Restrictive cardiomyopathy. Naturally, such forecast issues are by their nature unpredictable.

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise